Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SHE:301096)
China · Delayed Price · Currency is CNY 55.72
+0.58 (1.05%)
At close: Jun 18, 2026
SHE:301096 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | -51.39 | -90.4 | -52.74 | 271.97 | 194.16 | 111.09 |
Depreciation & Amortization | 157.64 | 157.64 | 145.8 | 90.6 | 64.49 | 35.48 |
Other Amortization | 0.58 | 0.58 | 0.36 | 3.89 | 11 | 8.62 |
Loss (Gain) From Sale of Assets | -0.22 | -0.22 | - | -0.78 | -0.02 | - |
Asset Writedown & Restructuring Costs | 0 | 0 | 0.01 | 0.03 | 0.03 | 4.67 |
Loss (Gain) From Sale of Investments | 11.8 | 11.8 | 5.59 | 0.11 | 1.06 | 0.65 |
Provision & Write-off of Bad Debts | 26.49 | 26.49 | 38.07 | 21.63 | 9.16 | - |
Other Operating Activities | 52.54 | 28.37 | 19.79 | 7.64 | 3.8 | 2.98 |
Change in Accounts Receivable | -211.65 | -211.65 | -252.41 | -399.31 | -125.29 | -100.21 |
Change in Inventory | -5.64 | -5.64 | -88.2 | -28.55 | -43.2 | -19.23 |
Change in Accounts Payable | -71.93 | -71.93 | 3.26 | 78.49 | 135.25 | 109.86 |
Change in Other Net Operating Assets | 1.63 | 1.63 | -28.27 | 44.69 | 35.2 | 3.83 |
Operating Cash Flow | -91.47 | -154.64 | -195.86 | 90.45 | 259.41 | 145.42 |
Operating Cash Flow Growth | - | - | - | -65.13% | 78.38% | 167.52% |
Capital Expenditures | -98.41 | -97.92 | -395.1 | -688.6 | -591.58 | -248.45 |
Sale of Property, Plant & Equipment | 0.41 | 0.42 | - | 0.23 | 0.55 | 0.02 |
Cash Acquisitions | - | - | -13.43 | - | - | - |
Divestitures | - | - | - | 45.98 | - | - |
Investment in Securities | -20.38 | -27.53 | -143.46 | -52.29 | -76.12 | - |
Other Investing Activities | 67.5 | 4.22 | 87.45 | -72.73 | -23.72 | -2.73 |
Investing Cash Flow | -50.89 | -120.81 | -464.54 | -767.42 | -690.87 | -251.16 |
Long-Term Debt Issued | - | 1,061 | 1,244 | 469 | 300 | 131.75 |
Total Debt Issued | 1,151 | 1,061 | 1,244 | 469 | 300 | 131.75 |
Long-Term Debt Repaid | - | -900.55 | -905.93 | -103.07 | -575.6 | -19 |
Total Debt Repaid | -973.51 | -900.55 | -905.93 | -103.07 | -575.6 | -19 |
Net Debt Issued (Repaid) | 177.77 | 160.73 | 338.41 | 365.93 | -275.6 | 112.75 |
Issuance of Common Stock | - | - | 8.89 | 21.98 | - | 1,891 |
Repurchase of Common Stock | - | - | - | -50 | - | - |
Common Dividends Paid | -21.26 | -20.52 | -48.77 | -92.81 | -66.55 | -10.13 |
Other Financing Activities | -0.11 | -0.37 | -0.44 | -0.62 | -24.32 | -11.13 |
Financing Cash Flow | 156.41 | 139.84 | 298.09 | 244.48 | -366.48 | 1,982 |
Foreign Exchange Rate Adjustments | -0.05 | -0.08 | 0.01 | -0.13 | - | - |
Net Cash Flow | 14 | -135.68 | -362.29 | -432.62 | -797.93 | 1,876 |
Free Cash Flow | -189.88 | -252.56 | -590.96 | -598.15 | -332.16 | -103.02 |
Free Cash Flow Margin | -26.75% | -37.25% | -73.69% | -58.79% | -54.68% | -27.52% |
Free Cash Flow Per Share | -1.75 | -2.32 | -5.49 | -5.52 | -3.06 | -1.27 |
Cash Interest Paid | - | - | 0.43 | 0.41 | - | - |
Cash Income Tax Paid | 9.05 | 11.71 | -5.26 | 0.95 | -41.84 | 16.83 |
Levered Free Cash Flow | -179.97 | -215.81 | -824.48 | -550.77 | -520.34 | -104.48 |
Unlevered Free Cash Flow | -166.07 | -202.68 | -813.89 | -546.39 | -519.52 | -102.19 |
Change in Working Capital | -288.92 | -288.92 | -352.73 | -304.63 | -24.27 | -18.06 |